Table 1 Baseline characteristics of Parkinson's disease patients and their risk set-matched cohort
Variables | Total | Parkinson’s disease (N = 17,143) | Matched Control (N = 17,143) | Standardized Difference | ||||
|---|---|---|---|---|---|---|---|---|
Total | 34,286 | (100.0) | 17,143 | (50.0) | 17,143 | (50.0) | ||
Sex | 0 | |||||||
Male | 12,922 | (37.7) | 6,461 | (37.7) | 6,461 | (37.7) | ||
Female | 21,364 | (62.3) | 10,682 | (62.3) | 10,682 | (62.3) | ||
Age (Mean, SD) | 71.10 | 6.02 | 71.10 | 6.02 | 71.10 | 6.02 | 0 | |
Household income level | 0.0143 | |||||||
Low | 9,428 | (27.5) | 4,767 | (27.8) | 4,661 | (27.2) | ||
Mid | 9,865 | (28.8) | 4,924 | (28.7) | 4,941 | (28.8) | ||
High | 14,993 | (43.7) | 7,452 | (43.5) | 7,541 | (44.0) | ||
Region | 0.0047 | |||||||
Metropolitan | 11,025 | (32.2) | 5,515 | (32.2) | 5,510 | (32.1) | ||
City | 7,457 | (21.7) | 3,743 | (21.8) | 3,714 | (21.7) | ||
Rural | 15,804 | (46.1) | 7,885 | (46.0) | 7,919 | (46.2) | ||
Social Security | 0.0158 | |||||||
Insurance (Regional) | 11,743 | (34.3) | 5,935 | (34.6) | 5,808 | (33.9) | ||
Insurance (Corporate) | 17,853 | (52.1) | 8,883 | (51.8) | 8,970 | (52.3) | ||
Medical Aid | 4,690 | (13.7) | 2,325 | (13.6) | 2,365 | (13.8) | ||
Disability | 0.0124 | |||||||
No | 33,978 | (99.1) | 16,979 | (99.0) | 16,999 | (99.2) | ||
Yes | 308 | (0.9) | 164 | (1.0) | 144 | (0.8) | ||
Charlson Comorbidity Index (CCI) | 0.0156 | |||||||
0 | 18,583 | (54.2) | 9,285 | (54.2) | 9,298 | (54.2) | ||
1 | 8,350 | (24.4) | 4,136 | (24.1) | 4,214 | (24.6) | ||
2 | 3,939 | (11.5) | 1,984 | (11.6) | 1,955 | (11.4) | ||
≥ 3 | 3,414 | (10.0) | 1,738 | (10.1) | 1,676 | (9.8) | ||
Medication history | ||||||||
Antidiabetic agents | 0.0037 | |||||||
No | 29,540 | (86.2) | 14,759 | (86.1) | 14,871 | (86.7) | ||
Yes | 4,746 | (13.8) | 2,384 | (13.9) | 2,362 | (13.8) | ||
Antihypertensive agents | -0.0042 | |||||||
No | 20,327 | (59.3) | 10,181 | (59.4) | 10,146 | (59.2) | ||
Yes | 13,959 | (40.7) | 6,962 | (40.6) | 6,997 | (40.8) | ||
Lipid-lowering agents | 0.0409 | |||||||
No | 31,319 | (91.3) | 15,561 | (90.8) | 15,758 | (91.9) | ||
Yes | 2,967 | (8.7) | 1,582 | (9.2) | 1,385 | (8.1) | ||
Antidepressive agents | 0.0016 | |||||||
No | 30,211 | (88.1) | 15,101 | (88.1) | 15,110 | (88.1) | ||
Yes | 4,075 | (11.9) | 2,042 | (11.9) | 2,033 | (11.9) | ||
Medication history | ||||||||
Malignant neoplasm | 0.0221 | |||||||
No | 33,307 | (97.1) | 16,622 | (97.0) | 16,685 | (97.3) | ||
Yes | 979 | (2.9) | 521 | (3.0) | 458 | (2.7) | ||
Ischemic heart disease | 0.0120 | |||||||
No | 31,545 | (92.0) | 15,707 | (91.6) | 15,838 | (92.4) | ||
Yes | 2,741 | (8.0) | 1,436 | (8.4) | 1,305 | (7.6) | ||
Stroke | 0.0282 | |||||||
No | 32,478 | (94.7) | 16,216 | (94.6) | 16,262 | (94.9) | ||
Yes | 1,808 | (5.3) | 927 | (5.4) | 881 | (5.1) | ||